Novo Nordisk (NVO) said on Thursday that it will take legal and regulatory steps in response to plans by Hims & Hers Health (HIMS) to launch low-cost compounded versions of its oral obesity therapy, ...

Led by Professor Fu Jin, the study addresses a critical challenge in radiation therapy: balancing the computational speed and accuracy of EPID-based dose verification. EPID has emerged as a key tool ...